Motif ID: Mecp2
Z-value: 2.793
Transcription factors associated with Mecp2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Mecp2 | ENSMUSG00000031393.10 | Mecp2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mecp2 | mm10_v2_chrX_-_74085586_74085652 | -0.10 | 7.0e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 17.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
3.5 | 10.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.3 | 13.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.6 | 2.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
2.4 | 2.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
2.3 | 6.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.3 | 6.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.0 | 6.0 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
2.0 | 4.0 | GO:0072190 | ureter urothelium development(GO:0072190) |
1.9 | 13.0 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
1.8 | 5.5 | GO:0071898 | odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.8 | 5.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.8 | 5.3 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.6 | 9.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.6 | 4.9 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.6 | 6.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
1.6 | 4.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.6 | 1.6 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
1.4 | 7.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.4 | 1.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.4 | 2.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.4 | 10.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.3 | 6.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.3 | 3.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.3 | 1.3 | GO:0051450 | myoblast proliferation(GO:0051450) regulation of myoblast proliferation(GO:2000291) |
1.3 | 3.8 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
1.2 | 7.3 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 4.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.2 | 5.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.2 | 5.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.1 | 1.1 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
1.1 | 13.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.1 | 4.5 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
1.1 | 4.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.1 | 3.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.1 | 5.4 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
1.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 3.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
1.1 | 3.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.1 | 3.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
1.0 | 4.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.0 | 4.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.0 | 4.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.0 | 4.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.0 | 3.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.0 | 2.0 | GO:0048382 | mesendoderm development(GO:0048382) |
1.0 | 4.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.0 | 1.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.0 | 1.0 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
1.0 | 4.0 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.0 | 2.9 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.0 | 2.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 6.8 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
1.0 | 2.9 | GO:0060242 | contact inhibition(GO:0060242) |
1.0 | 3.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.9 | 5.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.9 | 3.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.9 | 3.7 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 0.9 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.9 | 1.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.9 | 1.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.9 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.9 | 2.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.9 | 4.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 0.9 | GO:0048793 | pronephros development(GO:0048793) |
0.9 | 3.5 | GO:0021764 | amygdala development(GO:0021764) |
0.9 | 1.7 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.9 | 1.7 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.9 | 0.9 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.9 | 1.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.9 | 3.4 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.9 | 0.9 | GO:1903960 | regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) regulation of anion transmembrane transport(GO:1903959) negative regulation of anion transmembrane transport(GO:1903960) |
0.8 | 1.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 2.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.8 | 0.8 | GO:0003195 | tricuspid valve formation(GO:0003195) |
0.8 | 7.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.8 | 2.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 1.6 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.8 | 3.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.8 | 3.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.8 | 2.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.8 | 3.0 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.7 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.7 | 3.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.7 | 3.0 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 3.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 0.7 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.7 | 0.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.7 | 3.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 2.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.7 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 2.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 3.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.0 | GO:0030421 | defecation(GO:0030421) |
0.7 | 2.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 2.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 0.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.7 | 2.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 1.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.7 | 2.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.6 | 1.9 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.6 | 3.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 3.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 1.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.6 | 1.9 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.6 | 2.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.6 | 1.3 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.6 | 0.6 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.6 | 4.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.6 | 1.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.6 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.6 | 4.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 1.8 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 1.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 3.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 1.8 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.6 | 4.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 3.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.6 | 3.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.6 | 1.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.6 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 1.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.6 | 5.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.6 | 2.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.6 | 1.7 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.6 | 2.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 2.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 5.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 1.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 1.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 1.7 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
0.6 | 5.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 1.7 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.6 | 3.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 1.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.6 | 2.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.5 | 1.6 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.5 | 1.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.5 | 2.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 1.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 3.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.5 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.5 | 2.6 | GO:0051132 | NK T cell activation(GO:0051132) |
0.5 | 2.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 4.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 1.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.5 | GO:0035878 | nail development(GO:0035878) |
0.5 | 1.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.5 | 1.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.5 | 2.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 2.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 2.5 | GO:0003174 | mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) |
0.5 | 1.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 3.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 3.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 2.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.5 | 2.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 1.4 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.5 | 1.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 4.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 1.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 1.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.5 | 0.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.5 | 1.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 1.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.5 | 2.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 0.9 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 2.8 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.5 | 0.9 | GO:0002034 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.5 | 1.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 0.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 2.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 5.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.5 | 1.4 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.5 | 3.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 0.5 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.3 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 1.8 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.4 | 1.3 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.4 | 2.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 3.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 6.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 1.3 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
0.4 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 2.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 1.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 6.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 2.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 1.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 | 0.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 1.3 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.4 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 0.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.4 | 1.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 | 1.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 1.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 1.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 2.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.4 | 8.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.4 | 0.8 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.4 | 4.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 1.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.4 | 1.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 0.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 2.8 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.4 | 4.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 0.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.4 | 1.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 3.6 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.4 | 1.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 0.4 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 3.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 0.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 2.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 4.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 0.4 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.4 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 1.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.4 | 1.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.1 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.4 | 1.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.4 | 2.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 0.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 3.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 1.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 0.4 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) |
0.4 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.4 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 0.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.4 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.4 | 0.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.4 | 3.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 1.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.4 | 1.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.4 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.4 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.4 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.4 | 1.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 5.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 2.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 0.3 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.3 | 1.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.3 | 1.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 1.0 | GO:0003360 | brainstem development(GO:0003360) |
0.3 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.4 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.3 | 2.0 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.3 | 2.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.0 | GO:1901355 | response to rapamycin(GO:1901355) |
0.3 | 1.0 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.3 | 2.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 1.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 3.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 4.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 3.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 6.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 2.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 2.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 2.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 2.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 3.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 1.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.3 | 4.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 2.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 1.0 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.3 | 2.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 1.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 1.6 | GO:1904721 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.3 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 0.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.3 | 0.3 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 0.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 0.9 | GO:0036292 | DNA rewinding(GO:0036292) |
0.3 | 0.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.3 | 0.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 0.3 | GO:0051252 | regulation of RNA metabolic process(GO:0051252) |
0.3 | 2.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 3.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 4.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 0.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 4.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 1.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 1.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.3 | GO:1900119 | regulation of execution phase of apoptosis(GO:1900117) positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 0.9 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.3 | 1.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.3 | 1.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.3 | 2.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 1.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 3.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.7 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 1.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.3 | 1.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.3 | 1.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 0.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.8 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.3 | 0.8 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.3 | 2.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 2.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 4.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.3 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.3 | 0.5 | GO:0036166 | phenotypic switching(GO:0036166) |
0.3 | 2.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 1.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 | 2.9 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 1.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 2.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 8.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 0.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.3 | 0.8 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
0.3 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 1.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 0.8 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.3 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 3.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.3 | 0.3 | GO:0060066 | oviduct development(GO:0060066) |
0.3 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 0.3 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.3 | 0.8 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 3.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 3.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 1.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 3.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.3 | 2.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 1.5 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 0.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.3 | 1.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.8 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 3.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 2.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 1.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.2 | 2.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 1.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 2.4 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.2 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.7 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.2 | 7.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 1.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.7 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.2 | 1.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 0.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.5 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.2 | 6.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.9 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 5.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.5 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.2 | 1.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.2 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 2.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 0.9 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.9 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 1.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.7 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.2 | 1.1 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.2 | 0.7 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 1.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 2.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 2.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.9 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
0.2 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 2.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 2.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.7 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.2 | 0.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 0.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 2.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 1.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.2 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.6 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 1.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 0.6 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.2 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.6 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 3.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 2.1 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.6 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 2.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.6 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
0.2 | 1.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.4 | GO:0040010 | regulation of growth rate(GO:0040009) positive regulation of growth rate(GO:0040010) |
0.2 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 0.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 1.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 2.0 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 1.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.2 | GO:1903894 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 3.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.6 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 2.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 1.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.2 | 2.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.6 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.7 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.2 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.7 | GO:0045333 | cellular respiration(GO:0045333) |
0.2 | 0.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 1.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.4 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 1.1 | GO:0071476 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.2 | 0.2 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 1.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 3.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 1.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 2.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.4 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.3 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.3 | GO:0000479 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 3.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 1.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.5 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.8 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.2 | 0.5 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 2.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 1.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.3 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 0.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.2 | 0.5 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 0.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 4.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.2 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.8 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 0.5 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.5 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.7 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.3 | GO:0006507 | GPI anchor release(GO:0006507) |
0.1 | 0.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 2.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 1.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.4 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.1 | 0.9 | GO:0046602 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.4 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.8 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 2.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 2.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0061075 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of neural retina development(GO:0061074) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) regulation of amacrine cell differentiation(GO:1902869) positive regulation of amacrine cell differentiation(GO:1902871) |
0.1 | 0.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 2.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 2.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.1 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.7 | GO:0045830 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) positive regulation of isotype switching(GO:0045830) |
0.1 | 3.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 2.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 1.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.7 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 3.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.3 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of cell killing(GO:0031342) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 1.9 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.5 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.6 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.9 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.6 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.1 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.1 | 0.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 3.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.4 | GO:1903912 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 1.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.6 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.3 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
0.1 | 1.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 2.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 2.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 1.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 4.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0051934 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 1.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 1.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 1.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 1.0 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 1.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 2.8 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 2.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.8 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.4 | GO:0009212 | dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 1.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 2.8 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 1.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.3 | GO:1903936 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.1 | 1.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.7 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.7 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 1.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.4 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.1 | 1.3 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 1.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 2.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.1 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) |
0.1 | 1.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.5 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) tRNA catabolic process(GO:0016078) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.1 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 2.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.3 | GO:0061647 | histone H3-K9 modification(GO:0061647) |
0.1 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 2.2 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 3.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 1.1 | GO:0036296 | response to increased oxygen levels(GO:0036296) |
0.1 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.3 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.9 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 2.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) 2'-deoxyribonucleotide biosynthetic process(GO:0009265) dUDP metabolic process(GO:0046077) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.1 | 7.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 3.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 2.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 2.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.1 | 0.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.8 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.5 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 1.0 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 2.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) L-ascorbic acid metabolic process(GO:0019852) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 4.0 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 1.1 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.1 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 1.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.2 | GO:0050716 | regulation of interleukin-1 secretion(GO:0050704) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.8 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.6 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.4 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.1 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 1.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 1.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.1 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0016458 | gene silencing(GO:0016458) gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:1903294 | glutamate secretion, neurotransmission(GO:0061535) regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.1 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 1.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.3 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:0044829 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 2.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.2 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 2.3 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.6 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.9 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 1.2 | GO:0032608 | interferon-beta production(GO:0032608) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 3.8 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0030811 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 1.5 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.2 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.0 | 0.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.2 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
0.0 | 0.7 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.5 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.1 | GO:0033363 | acrosome assembly(GO:0001675) secretory granule organization(GO:0033363) |
0.0 | 0.1 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.2 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0019083 | viral transcription(GO:0019083) |
0.0 | 0.2 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.2 | GO:1901071 | N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.2 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.0 | 1.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.0 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) myelin maintenance(GO:0043217) |
0.0 | 0.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0048753 | pigment granule organization(GO:0048753) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.0 | 1.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.0 | 0.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.3 | 6.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.9 | 11.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 5.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.6 | 6.5 | GO:0060187 | cell pole(GO:0060187) |
1.6 | 4.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 9.6 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 3.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.0 | 2.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.9 | 2.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 3.6 | GO:0008623 | CHRAC(GO:0008623) |
0.9 | 3.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.8 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
0.8 | 2.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.8 | 7.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.8 | 2.4 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 4.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.7 | 8.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 2.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.7 | 2.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.7 | 2.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 3.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 3.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 2.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 3.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 4.1 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 2.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 5.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.6 | 14.8 | GO:0001741 | XY body(GO:0001741) |
0.6 | 3.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 2.1 | GO:0090537 | CERF complex(GO:0090537) |
0.5 | 1.6 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.5 | 2.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.5 | 1.5 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.5 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 1.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 1.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.5 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 1.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 3.7 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 6.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 3.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 3.5 | GO:0005818 | aster(GO:0005818) |
0.4 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 4.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 3.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 2.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 1.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 1.2 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.4 | 2.3 | GO:0034448 | EGO complex(GO:0034448) |
0.4 | 1.2 | GO:0000801 | central element(GO:0000801) |
0.4 | 1.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 0.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.4 | 1.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 2.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 2.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 0.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.3 | 2.0 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 2.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 2.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 1.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.3 | 6.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 1.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.3 | 0.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 1.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 5.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 6.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 3.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 0.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.8 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 3.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 4.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 4.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 2.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 0.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 2.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 3.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.2 | 1.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 1.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 0.9 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.7 | GO:0071914 | prominosome(GO:0071914) |
0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 22.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 3.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 2.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 9.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 3.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 3.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 4.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 3.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 4.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 3.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.2 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 2.8 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.4 | GO:0097413 | Lewy body(GO:0097413) Lewy body core(GO:1990037) |
0.2 | 2.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 30.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 4.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 5.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 3.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 1.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 4.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.3 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 6.1 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 2.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 14.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 2.4 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.2 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 3.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.0 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 2.0 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.7 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 1.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 7.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 27.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 4.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.4 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 3.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 22.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 6.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 2.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 4.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.1 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 1.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 2.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 3.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 5.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 3.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 5.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 4.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 4.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 4.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 7.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 2.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 4.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 3.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 4.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 3.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.1 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 2.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 2.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 6.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 2.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 2.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 2.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.2 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.0 | 0.5 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 10.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 4.1 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.0 | 1.7 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 6.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 2.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 45.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.9 | GO:0044452 | nucleolar part(GO:0044452) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.7 | 13.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.7 | 5.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 4.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.2 | 3.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 4.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.2 | 4.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 4.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.1 | 4.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.1 | 1.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.0 | 3.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
1.0 | 3.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.0 | 5.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.0 | 2.9 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.9 | 5.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.9 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.8 | 5.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 2.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.8 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 4.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 4.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 1.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 2.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.8 | 7.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.8 | 10.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 3.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.8 | 2.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.8 | 2.3 | GO:0004335 | galactokinase activity(GO:0004335) |
0.8 | 3.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.7 | 17.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 3.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 11.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 2.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.6 | 2.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 3.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 10.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 2.5 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.6 | 1.9 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.6 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 2.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.6 | 1.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 3.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 1.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 3.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 1.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.6 | 2.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.6 | 1.7 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.5 | 4.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 4.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 5.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 3.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 4.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 5.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 2.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 2.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 3.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 4.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 2.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.5 | 2.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 2.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 1.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.5 | 5.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 2.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 5.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 1.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 8.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 2.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.5 | 0.9 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.5 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 3.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 3.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 1.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.4 | 5.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 2.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 1.7 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.4 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.2 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.4 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 2.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 3.6 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 5.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 2.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.4 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 4.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 6.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.4 | 1.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 8.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 6.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.4 | 1.5 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.4 | 2.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.1 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.4 | 2.2 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 3.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.4 | 5.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 5.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.4 | 2.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 5.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 4.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 1.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 3.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 6.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 8.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.0 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.3 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.3 | 1.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.3 | 3.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 2.0 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.3 | 1.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 15.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 6.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 1.0 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.3 | 1.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 4.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 2.3 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.3 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 1.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.3 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 3.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 3.8 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 4.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 1.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.9 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 0.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 3.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.3 | 0.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.3 | 1.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 1.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 3.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.1 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 1.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 9.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 3.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.3 | 2.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 1.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 6.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.2 | 1.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 2.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 5.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 0.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 2.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.7 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.2 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 1.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 1.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 7.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 1.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 1.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.2 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 5.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 7.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 2.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 2.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 2.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 1.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 1.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 3.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 1.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.6 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 3.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.2 | 0.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 5.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.9 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.2 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 4.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 1.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 0.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 2.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 3.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 2.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 5.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 10.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.5 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 1.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 2.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 6.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.1 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.1 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.7 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 2.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 5.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 7.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 2.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.6 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.1 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 2.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 4.7 | GO:0000975 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 8.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.5 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 4.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.7 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 1.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 3.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 4.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 1.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 3.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 25.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.6 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 9.5 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 4.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.2 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 1.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 1.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.5 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 3.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.2 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 5.9 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 2.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.1 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.1 | 11.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 0.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.7 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 2.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 2.3 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 2.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 2.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 1.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.8 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 1.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 6.5 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.0 | 9.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 1.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 5.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 1.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.6 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.3 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 1.0 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 21.6 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.7 | 4.9 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.7 | 6.0 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 7.7 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 24.3 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 4.7 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.4 | 13.4 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.3 | 23.4 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 1.4 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 17.8 | PID_BMP_PATHWAY | BMP receptor signaling |
0.3 | 11.6 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 3.1 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 8.1 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.2 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 5.5 | PID_IGF1_PATHWAY | IGF1 pathway |
0.3 | 18.7 | PID_E2F_PATHWAY | E2F transcription factor network |
0.3 | 0.9 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
0.3 | 6.5 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.2 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.3 | 16.3 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.3 | 8.2 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.3 | 13.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.3 | 1.3 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.7 | PID_IL5_PATHWAY | IL5-mediated signaling events |
0.2 | 0.7 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 4.3 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.3 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.3 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.0 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.8 | PID_MYC_PATHWAY | C-MYC pathway |
0.2 | 6.0 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.2 | 6.6 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.2 | 8.9 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.2 | 5.5 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 6.4 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.2 | 7.5 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.2 | 0.2 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 2.1 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 5.6 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.2 | 2.9 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.4 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 2.6 | PID_ATR_PATHWAY | ATR signaling pathway |
0.2 | 11.2 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.2 | 11.3 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 1.6 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.2 | 1.8 | PID_EPO_PATHWAY | EPO signaling pathway |
0.2 | 4.6 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.2 | 1.5 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.7 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.5 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 11.5 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 6.5 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.9 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.5 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.3 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.1 | 4.2 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.1 | 1.8 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.1 | 5.9 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.8 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.8 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.6 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.1 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.1 | 3.3 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.1 | 1.6 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.3 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.0 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.1 | 5.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.1 | 1.2 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.1 | 2.0 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.5 | PID_IL27_PATHWAY | IL27-mediated signaling events |
0.1 | 2.0 | PID_FOXO_PATHWAY | FoxO family signaling |
0.1 | 0.7 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.5 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.7 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.1 | PID_FGF_PATHWAY | FGF signaling pathway |
0.1 | 1.0 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.0 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.1 | 2.6 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 2.4 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 8.4 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.3 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.4 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.1 | 0.4 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.4 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
0.1 | 0.3 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 2.3 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.9 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 10.1 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 0.7 | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | Genes involved in Processive synthesis on the lagging strand |
0.6 | 19.1 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.6 | 3.6 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 9.3 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 13.0 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.6 | 9.6 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 18.0 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 3.3 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 1.4 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 0.5 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 0.9 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 5.8 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 6.5 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.4 | 4.9 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 5.2 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 4.7 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 2.8 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 7.3 | REACTOME_BASE_EXCISION_REPAIR | Genes involved in Base Excision Repair |
0.3 | 0.3 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.4 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 8.7 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 5.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 9.3 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.3 | 1.3 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 2.6 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 2.6 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.5 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.6 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 7.6 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.3 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 10.0 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 3.0 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 7.7 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 0.9 | REACTOME_CELL_CYCLE_CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 0.6 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 5.8 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.3 | 4.1 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 2.2 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.4 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 1.9 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 0.8 | REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.3 | 2.6 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.7 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 2.6 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 3.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.2 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.5 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 1.9 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 1.4 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.8 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.5 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.7 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.8 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 4.4 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 0.2 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 10.5 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.4 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.3 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 0.2 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 11.5 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.0 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
0.2 | 5.0 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.2 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.8 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 5.7 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 6.5 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.4 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.2 | 3.0 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 3.3 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.8 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.4 | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.6 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 10.4 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 0.7 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.5 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.6 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.5 | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 0.7 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 4.6 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.5 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.2 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 8.8 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 6.2 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.6 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.3 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.4 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 8.0 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.4 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.5 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.7 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.5 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 3.7 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.9 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 5.9 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.2 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.0 | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.0 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 9.1 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.4 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 4.6 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.1 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.4 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 7.5 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.0 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.5 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.1 | 4.5 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.1 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.1 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.7 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 3.1 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 18.8 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.0 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.7 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.1 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.2 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.6 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.3 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.7 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.5 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.6 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.7 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 6.7 | REACTOME_DNA_REPLICATION | Genes involved in DNA Replication |
0.1 | 0.5 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.2 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 3.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 7.4 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.6 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.3 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.4 | REACTOME_KINESINS | Genes involved in Kinesins |
0.1 | 0.9 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.1 | 0.4 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.8 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.4 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.8 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.7 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.2 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.8 | REACTOME_DIABETES_PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.5 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.1 | 0.6 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.5 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.6 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 9.9 | REACTOME_TRANSLATION | Genes involved in Translation |
0.1 | 2.7 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.3 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.2 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.4 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.2 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.3 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.4 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.3 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.3 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.3 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.3 | REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 3.0 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 1.9 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.2 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 2.2 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.2 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.7 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.3 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.5 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.5 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |